Austria – Today Lexogen, a transcriptomics and next generation sequencing company, announces the start of its RNA-Seq service, which focuses on gene expression profiling using Lexogen’s proprietary QuantSeq technology. Lexogen’s QuantSeq 3’ mRNA-Seq Library Prep Kit has already been recognized as one of the fastest, most cost-efficient, and accurate methods for expression profiling using next […]

Financing led by ARCH Venture Partners with the largest investment by Johnson & Johnson Innovation; includes additional strategic industry and venture investors GRAIL plans a second close with institutional investors to bring the total raised in the Series B to over $1 billion MENLO PARK, Calif. — GRAIL, Inc., a life sciences company whose mission […]

Mountain View, CA—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of WaferGen Bio-systems, Inc. (“WaferGen”), WaferGen has become a wholly-owned subsidiary of TBUSH as of February 28, 2017 (US local time). Under the merger agreement executed with WaferGen, TBUSH paid 35.9 million US dollars to acquire 100% of the equity […]

NEW YORK — Phosphorus, a computational genomics and clinical genetic testing company, announced today the formation of the Phosphorus Scientific Advisory Board, an established group of medical and science experts chosen to advise the company on the development of new products and the company’s large-scale, multi-site research initiatives. “We’ve gathered some of the top leaders in […]

SHANGHAI, CAMBRIDGE, Mass. and REYKJAVIK, Iceland — WuXi NextCODE, a WuXi AppTec group company and the contract genomics organization enabling precision medicine worldwide, today announced that the company’s chief operating officer Hannes Smarason has been appointed as the company’s chief executive officer, and WuXi AppTec senior vice presidents John Long and Alex Fowkes have been named […]

Shenzhen, China– Recently, BGI announced that Dr. Leroy Hood, a world renowned scientist and genomics pioneer, has joined the company’s Scientific Advisory Board. Dr. Hood, a pioneer in the systems approach to biology and medicine, is president and co-founder of the Institute for Systems Biology and senior vice president and chief scientific officer of Providence […]

iHope Network Members Include Illumina, GeneDx, Genome.One, and HudsonAlpha; Dedicated to Help Find Answers for Underserved Families with Children Facing Rare and Undiagnosed Diseases Through whole-genome sequencing – the process of determining the genetic code or instructions in the cells within a person’s body – the iHope Network and their respective clinical partners strive to end […]

IRVINE, Calif. — Zymo Research announces the launch of its Discovery Series™DNA and RNA purification kits. The new product line includes eight of Zymo Research’s most popular kits in a new 5- and 10-prep/reaction format. The Discovery Series™ kits are designed to maximize flexibility and provide convenience for small volume research laboratories. An average sized nucleic […]

CAMBRIDGE, UK – 27 February, 2017 – Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners (Amadeus) participated alongside new investor, Parkwalk Advisors (Parkwalk). Congenica will use the Series B […]

OMAHA, Neb.–Transgenomic, Inc. (TBIO) (OTCQB: TBIO) today reported that trading in its shares will begin on the OTCQB exchange under the ticker “TBIO” effective at the open of business on February 22, 2017. On February 17, 2017, the Company received written notification from the staff of the Nasdaq Stock Market LLC (“Nasdaq”) that it had […]